RSV vaccine uptake will start slower than shingles shot: GSK CEO

A Surprising Finding Leads to an RSV Vaccine Breakthrough - Bloomberg

GSK says its RSV vaccine for older adults gives long-term protection

GSK's RSV vaccine bolsters bottom line, company raises full-year guidance

CDC Meeting on RSV Vaccines Could Be Pivotal for GSK, Moderna - Barron's

Exhibit 15.2

GSK expects RSV vaccine uptake will be slower than shingles vaccine-CEO, ET HealthWorld

How a big pharma company stalled a potentially lifesaving vaccine in pursuit of bigger profits

Blog Archives - ENCORE Research Group

FDA Approves First-Ever RSV Vaccine After Brutal 2022 Season

GSK reports blockbuster sales RSV shot Arexvy in race vs. Pfizer

GSK CEO Emma Walmsley On RSV Vaccines

RSV vaccine uptake will start slower than shingles shot: GSK CEO

Covid, RSV, flu vaccines: How to decide whether to get them together

RSV vaccine: CDC panel recommends Pfizer, GSK shots for adults over 60

Shingrix shingles vaccine protects seniors for 10 years, new data show